title: Long-term interferon-alpha therapy does not affect sex hormones in males with chronic hepatitis C.
abstract: The effects of interferon-alpha (IFN-alpha), given at a dosage of 6 MU thrice weekly for 12 months, on gonadal function were investigated in 18 males affected by chronic hepatitis C. Periodically, all patients were clinically monitored and questioned about sexual function. Gonadotropin and serum androgen concentrations (follicle-stimulating hormone, luteinizing hormone, total testosterone, free testosterone, androstenedione, dehydroepiandrosterone, dehydroepiandrosterone sulfate, and sex hormone binding globulin) were tested every 3 months. Ten of 18 patients (55%) responded to IFN-alpha therapy. Serum total testosterone and sex hormone binding globulin values decreased slightly at the third month of treatment, then returned to baseline values. Serum free testosterone and other sex hormones remained essentially unchanged during IFN-alpha therapy. Four patients (22.2%) complained of sexual dysfunction (impaired libido, erectile failure, and impaired ejaculation), which was unrelated to any significant hormonal change and resolved after IFN therapy was stopped. Serum sex hormones values did not differ between responders and nonresponders to IFN-alpha. This study indicates that 12 months treatment with 6 MU of IFN-alpha thrice weekly does not significantly affect gonadal function in men with chronic hepatitis C. The sexual dysfunction observed could be ascribed to such other side effects of IFN as asthenia, fatigue, or anxiety, or it could have a psychologic basis.
authors.affiliation: Instituto Malattie Infettive, Università degli studi di Napoli Federico II, Naples, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Piazza
authors.forename: G
authors.initials: G
authors.lastname: Tosone
authors.forename: G
authors.initials: G
authors.lastname: Borgia
authors.forename: R
authors.initials: R
authors.lastname: Orlando
authors.forename: G
authors.initials: G
authors.lastname: Fenzi
authors.forename: M
authors.initials: M
authors.lastname: Vitale
authors.forename: A
authors.initials: A
authors.lastname: Bloise
authors.forename: A
authors.initials: A
authors.lastname: Mariano
authors.forename: V
authors.initials: V
authors.lastname: Macchia
mesh_terms: D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D012739:Gonadal Steroid Hormones / Q000097:blood*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D012739:Gonadal Steroid Hormones; D016898:Interferon-alpha